Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists
- 1 May 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 164 (3) , 445-454
- https://doi.org/10.1016/0014-2999(89)90252-5
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmissionTrends in Pharmacological Sciences, 1987
- Trazodone and m-chlorophenylpiperazine Concentration in brain and receptor activity in regions in the brain associated with anxietyNeuropharmacology, 1985
- 5-HT-la and 5-HT-lb selectivity of two phenylpiperazine derivatives: Evidence for 5-HT-lb heterogeneityLife Sciences, 1985
- Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeysLife Sciences, 1983
- Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazineLife Sciences, 1983
- Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepamPsychopharmacology, 1982
- Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin releaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981